Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05285-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Yomna G Farag und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt. Hauptthemen laut MEDLINE: Stanozolol, Solid Phase Extraction, Limit of Detection, Molecularly Imprinted Polymers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German University in Cairo.
Abstract (Originalsprache)
Stanozolol, a synthetic derivative of testosterone, is one of the common doping drugs among athletes and bodybuilders. It is metabolized to a large extent and metabolites are detected in urine for a longer duration than the parent compound. In this study, a novel dummy molecularly imprinted polymer (DMIP) is developed as a sorbent for solid-phase extraction of stanozolol metabolites from spiked human urine samples. The optimized DMIP is composed of stanozolol as the dummy template, methacrylic acid as the functional monomer, and ethylene glycol dimethacrylate as the cross-linker in a ratio of 1:10:80. The extracted analytes were quantitively determined using a newly developed and validated ultrahigh-performance liquid chromatography tandem mass spectrometry method, where the limits of detection and quantitation were 0.91 and 1.81 ng mL −1 , respectively, fulfilling the minimum required performance limit decided on by the World Anti-Doping Agency. The mean percentage extraction recoveries for 3’-hydroxystanozolol, 4β-hydroxystanozolol, and 16β-hydroxystanozolol are 97.80% ± 13.80, 83.16% ± 7.50, and 69.98% ± 2.02, respectively. As such, the developed DMISPE can serve as an efficient cost-effective tool for doping and regulatory agencies for simultaneous clean-up of the stanozolol metabolites prior to their quantification. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt.
- Pharmaceutical Chemistry Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, 11835, Egypt. rasha.hanafi@guc.edu.eg.
- Department of Chemistry, School of Life and Medical Sciences, University of Hertfordshire Hosted By Global Academic Foundation, New Administrative Capital, Cairo, 4813001, Egypt.
Förderung
- German University in Cairo
Zitieren
APA
Farag, Y. G., Hanafi, R. S., & Hammam, M. A. (2024). Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05285-x
Vancouver
Farag YG, Hanafi RS, Hammam MA. Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05285-x
BibTeX
@article{Farag2024,
author = {Farag, Yomna G and Hanafi, Rasha S and Hammam, Mennatallah A},
title = {Novel dummy molecularly imprinted polymer for simultaneous solid-phase extraction of stanozolol metabolites from urine},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05285-x}
}
EUVIMED